Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron K Sato

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Discovery|July 29, 2024
Phage display technology and its impact in the discovery of novel protein-based drugsCatherine J Hutchings, Aaron K Sato
Drug Discovery Today|June 9, 2004
Phage display-derived peptides as therapeutic alternatives to antibodiesRobert C Ladner, Aaron K Sato, Jennifer Gorzelany, et al.
Current Opinion in Biotechnology|October 20, 2006
Therapeutic peptides: technological advances driving peptides into developmentAaron K Sato, Malini Viswanathan, Rachel B Kent, et al.
Journal of Chemical Information and Modeling|September 23, 2014
A general sequence processing and analysis program for protein engineeringRyan L Stafford, Erik S Zimmerman, Trevor J Hallam, et al.
Journal of Molecular Recognition : JMR|February 12, 2005
Discovery of human antibodies against the C5aR target using phage display technologyLili Huang, Aaron K Sato, Meena Sachdeva, et al.
Pharmaceutical Research|December 17, 2014
Methods to Make Homogenous Antibody Drug ConjugatesToni Kline, Alexander R Steiner, Kalyani Penta, et al.
Molecular Pharmaceutics|March 24, 2018
Toward a Ferrous Iron-Cleavable Linker for Antibody-Drug ConjugatesBenjamin Spangler, Toni Kline, Jeffrey Hanson, et al.
Expert Opinion on Drug Discovery|March 30, 2023
Discovery and design of G protein-coupled receptor targeting antibodiesSean M Peterson, Catherine J Hutchings, Cameron F Hu, et al.
Molecular Cancer Therapeutics|May 20, 2016
Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free Protein SynthesisNicolas V Currier, Shelley E Ackerman, James R Kintzing, et al.
Neoplasia (New York, N.Y.)|March 25, 2009
Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivoEdward Htun van der Horst, Lawrence Chinn, Min Wang, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Discovery|July 29, 2024
Phage display technology and its impact in the discovery of novel protein-based drugsCatherine J Hutchings, Aaron K Sato
Drug Discovery Today|June 9, 2004
Phage display-derived peptides as therapeutic alternatives to antibodiesRobert C Ladner, Aaron K Sato, Jennifer Gorzelany, et al.
Current Opinion in Biotechnology|October 20, 2006
Therapeutic peptides: technological advances driving peptides into developmentAaron K Sato, Malini Viswanathan, Rachel B Kent, et al.
Journal of Chemical Information and Modeling|September 23, 2014
A general sequence processing and analysis program for protein engineeringRyan L Stafford, Erik S Zimmerman, Trevor J Hallam, et al.
Journal of Molecular Recognition : JMR|February 12, 2005
Discovery of human antibodies against the C5aR target using phage display technologyLili Huang, Aaron K Sato, Meena Sachdeva, et al.
Pharmaceutical Research|December 17, 2014
Methods to Make Homogenous Antibody Drug ConjugatesToni Kline, Alexander R Steiner, Kalyani Penta, et al.
Molecular Pharmaceutics|March 24, 2018
Toward a Ferrous Iron-Cleavable Linker for Antibody-Drug ConjugatesBenjamin Spangler, Toni Kline, Jeffrey Hanson, et al.
Expert Opinion on Drug Discovery|March 30, 2023
Discovery and design of G protein-coupled receptor targeting antibodiesSean M Peterson, Catherine J Hutchings, Cameron F Hu, et al.
Molecular Cancer Therapeutics|May 20, 2016
Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free Protein SynthesisNicolas V Currier, Shelley E Ackerman, James R Kintzing, et al.
Neoplasia (New York, N.Y.)|March 25, 2009
Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivoEdward Htun van der Horst, Lawrence Chinn, Min Wang, et al.
Pageof 3